Dr. Sherman was instrumental in establishing and served as Principal Investigator for the Asian American Hepatitis B Program, a large-scale city-wide public health initiative. He is currently the Director of Clinical Trials at Concorde Medical Group, and has served as Principal Investigator for numerous studies. Dr. Sherman provides gastroenterology and liver disease consultation and management and is proficient in various endoscopic procedures, including upper endoscopy, capsule endoscopy, colonoscopy and ERCP. Dr. Sherman has been named to the New York Times Super Doctors list and New York Magazines Top Doctors list.

Dr. Sherman believes in the importance of appropriate screening colonoscopy to prevent colon cancer. He is excited about new treatments for Crohns disease and ulcerative colitis that allow a return to normal life, free of symptoms. He is encouraged by new simple treatments for hepatitis C that are tolerable and highly effective. He has been active in the community and public health approach to Hepatitis B in high risk groups and anticipates progress towards a cure. Dr. Sherman has broad expertise in the management of Gastro-Esophageal Reflux Disease, or GERD; he seeks to provide a definitive diagnosis and treatment plan and screen for the possibility of Barretts esophagus, a risk factor for esophageal cancer. Dr. Sherman recognizes the decline in quality of life for patients with irritable bowel syndrome or IBS, requiring individualized and multidisciplinary evaluation and treatment plans. Finally, Dr. Sherman recognizes the multifarious effects of obesity on ones health and looks forward to innovative endoscopic management to prevent complications of diabetes, hypertension and fatty liver disease.